Broad spectrum anti-RNA virus activities of titanium and vanadium substituted polyoxotungstates

Antiviral Research

Volumn 58, Issue 3, 2003, Pages 265-271

  Shigeta, Shibro ^a   Mori, Shuichi ^a   Kodama, Eiichi ^b   Kodama, Junko ^a   Takahashi, Kazuo ^a   Yamase, Toshihiro ^c  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

Antiviral; Dengue fever virus; HIV; Polyoxometalate; RNA virus

Indexed keywords

PM 1001; PM 1002; PM 43; PM 47; PM 518; PM 520; PM 523; TITANIUM DERIVATIVE; TUNGSTEN DERIVATIVE; VANADIUM DERIVATIVE;

ANIMAL CELL; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; CANINE DISTEMPER MORBILLIVIRUS; CELL GROWTH; CELL STRAIN; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DENGUE VIRUS; HEP 2 CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; INFLUENZA VIRUS A; INFRARED SPECTROMETRY; INHIBITION KINETICS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PARAINFLUENZA VIRUS 2; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; SUBSTITUTION REACTION; SYNCYTIUM; VERO CELL; VIRUS INDUCTION; VIRUS REPLICATION;

CANINE DISTEMPER VIRUS; DENGUE FEVER VIRUS; DISTEMPER VIRUS; FLAVIVIRIDAE; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN PARAINFLUENZA VIRUS 2; INFLUENZA A VIRUS; INFLUENZA VIRUS; ORTHOMYXOVIRIDAE; PARAMYXOVIRIDAE; RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS; RNA VIRUSES; SYNCYTIAL VIRUS;

EID: 0038735360     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-3542(03)00009-3     Document Type: Article

References (21)

1. Baba M., Schols D., Pauwels R., Nakashima H., De Clercq E. Sulfated polysaccharides as potent inhibitors of HIV-induced syncytium formation: a new strategy towards AIDS chemotherapy. J. Acquir. Immune Defic. Syndr. 3:1990;493-499.
2. Barnard D.L., Hill C.L., Gage T., Matheson J.E., Huffman J.H., Sidwell R.W., Otto M.I., Schinazi R.F. Potent inhibition of respiratory syncytial virus by polyoxometalates of several structural classes. Antivir. Res. 34:1997;27-37.
3. Fukuda N., Yamase T. In vitro antibacterial activity of vanadyl compounds against Streptococcus pneumoniae. Biol. Pharm. Bull. 20:1977;927-930.
4. Fukuda N., Yamase T., Tajima Y. Inhibitory effect of polyoxotungstates on the production of penicillin-binding proteins and β-lactamase against methicillin-resistant Staphylococcus aureus. Biol. Pharm. Bull. 22:1999;463-470.
5. Huffman J.H., Sidwell R.W., Barnard D.L., Morrison A., Otto M.J., Hill C.L., Schinazi R.F. Influenza virus inhibitory effects of a series of germanium- and silicon-centred polyoxometalates. Antivir. Chem. Chemother. 8:1997;75-83.
6. Ikeda S., Nishiya S., Yamamoto A., Yamase T., Nishimura C., De Clercq E. Activity of the Keggin polyoxotungstate PM-19 against herpes simplex virus type 2 infection in immunosuppressed mice role of peritoneal macrophage activation. J. Med. Virol. 41:1993;191-195.
7. Inouye Y., Fujimoto Y., Sugiyama M., Yoshida T., Yamase T. Structure-activity correlationship and strain specificiity of polyoxometalates in anti-human immunodeficiency virus activity. Biol. Pharm. Bull. 18:1995;996-1000.
8. 7- catalyst in acetonitrile. J. Mol. Catalysis A: Chemical. 142:1999;61-76.
9. Kimpton J., Emerman M. Detection of replication-component and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated β-galactosidase gene. J. Virol. 66:1992;2232-2239.
10. Mori S., Watanabe W., Shigeta S. A colorimetric LDH assay for the titration of infectivity and the evaluation of anti-viral activity against ortho- and paramyxoviruses. Tohoku J. Exp. Med. 177:1995;315-325.
11. Pauwels R., Balzarini J., Baba M., Snoeck R., Schols D., Herdewijin P., Desmyter J., De Clercq E. Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds. J. Virol. Methods. 20:1988;309-321.
12. Rhule J.T., Hill C.L., Judd D.A., Schinazi R.F. Polyoxometalates in medicine. Chem. Rev. 98:1998;327-358.
13. Shigeta S., Mori S., Watanabe J., Baba M., Khenkin C.L., Hill C.L., Schinazi R.F. In vitro antimyxovirus and anti-human immunodeficiency virus activities of polyoxometalates. Antivir. Chem. Chemother. 6:1995;114-122.
14. Shigeta S., Mori S., Watanabe J., Yamase T., Schinazi R.F., Hill C.L., Schinazi R.F. In vitro antimyxovirus activity and mechanism of anti-influenzavirus activity of polyoxometalates PM-504 and PM-523. Antivir. Chem. Chemother. 7:1996;346-352.
15. Shigeta S., Mori S., Watanabe J., Soeda S., Takahashi K., Yamase T. Synergistic anti-influenza virus A (H1N1) activities of PM-523 (polyoxometalate) and ribavirin in vitro and in vivo. Antimicrob. Agents Chemother. 41:1997;1423-1427.
16. Watanabe W., Konno K., Ijichi K., Inoue H., Yokota T., Shigeta S. MTT colorimetric assay system for the screening of anti-orthomyxo- and anti-paramyxoviral agents. J. Virol. Methods. 48:1994;257-265.
17. Yamamoto N., Schols D., De Clercq E., Debyser Z., Pauwels R., Balzarini J., Nakashima H., Baba M., Hosoya M., Snoeck R., Neyts J., Andrei G., Murrer B.A., Theobald B., Bossard G., Henson G., Abrams M., Picker D. Mechanism of anti-human immunodeficiency virus action of polyoxometalates, a class of broad spectrum antiviral agents. Mol. Pharmacol. 42:1992;1109-1117.
18. 183W -NMR and X-ray crystallographic studies on the peroxo complexes of the Ti substrated a Keggin typed tungstophosphates Bull. Chem. Soc. Jpn. 65:1992;1453-1459.
19. Yamase T., Ozeki T., Sakamoto H., Nishiya S., Yamamoto A. Structure of hexatitanooctadecatungstodigermanate. Bull. Chem. Soc. Jpn. 66:1993;103-108.
20. 12-. Chem. Lett. 2001:2001;56-57.
21. 12-. In: Yamase, T., Pope, M.T. (Eds.), Polyoxometalate Chemistry for Nano-composite Design. Plenum Press, New York.